Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Avacta lands top 10 US pharma buyer for Optim platform

07-Jun-2011

Related topics: Processing equipment, Processing, Globalisation

Analytical technology firm Avacta says it has won its first top ten US pharma customer in collaboration with marketing partner Pall Life Sciences.

The UK-based company, which provides analytical and diagnostic technologies and services to the pharmaceutical and animal healthcare sectors, has sold its Optim candidate identification platform to an unidentified US drug firm.

The Optim system can, according to Avactia, identify those candidates most suitable for development and to define the optimal processing conditions, which it said saves drugmakers time and money.

CEO Alastair Smith, Chief Executive of Avacta Group said that: “Today's order means we have already met the target of twelve Optim sales in the current year.